Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity

A main effector mechanism of rituximab (RTX) is the induction of complement-dependent cytotoxicity (CDC). However, this effector function is limited, because CLL cells are protected from complement-induced damage by regulators of complement activation (RCAs). A prominent RCA in fluid phase is factor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hörl, S, Bánki, Z, Huber, G, Ejaz, A, Windisch, D, Muellauer, B, Willenbacher, E, Steurer, M, Stoiber, H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3826035/
https://ncbi.nlm.nih.gov/pubmed/23760402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2013.169
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados